4D Molecular Therapeutics
FDMT • NASDAQ • Stock Fundamentals
4D Molecular Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO David H. Kirn, with a market cap of $461.9M.
Market Cap$461.9M
Employees171.0
CEODavid H. Kirn
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026
View reportNext EarningsAug 10, 2026 · in 2 monthsQ2 2026
Financials
Based on Q1 2026 filing
4D Molecular Therapeutics FAQ
Common questions about 4D Molecular Therapeutics
4D Molecular Therapeutics (FDMT) has a market capitalization of $461.9M and trades on NASDAQ.
4D Molecular Therapeutics has approximately 171 employees.